ArticleBMC public health2025
Unmet need for breast cancer screening among women of reproductive age in Ghana: a secondary analysis of the 2022 demographic and health survey.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Over-presentation of apolipoprotein E gene variants E3/E4 and cardiovascular disease risk factors among Ghanaian breast cancer patients.BMC cancer · 2026Article
- Burden, Regional Trends and Risk Factors of Breast, Cervical, Uterine, and Ovarian Cancers in Sub-Saharan Africa, 1990-2023: The Global Burden of Disease 2023.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnmet need for breast cancer screening refers to a situation where women within the recommended screening age group who have engaged with healthcare services in the last 12 months but have never undergone a breast examination by a healthcare professional. Gaining insights into the extent of unmet need for breast cancer screening is essential for designing targeted interventions to improve screening uptake and reduce screening inequalities. It is for this reason that the study sought to examine the prevalence and factors associated with unmet need for breast cancer screening among Ghanaian women.
methodsUsing the 2022 Ghana Demographic and Health Survey, we analyzed data of 3,317 women aged 25-49. Women aged 15-24 years were excluded in line with screening recommendations. Cross-tabulations, bivariable and multivariable logistic regression were performed.
resultsThere was a high unmet need for breast cancer screening among women in Ghana (67.7% [65.2-70.1]). Women who reported using the internet often had a lower likelihood of unmet need compared to those who never used the internet (AOR = 0.80, 95%CI: 0.64-1.00). Also, women aged 45-49 years had lower odds of unmet need than those aged 25-29 years (AOR = 0.59, 95%CI: 0.44-0.78). Compared to those with no formal education, women with secondary education (AOR = 0.56, 95%CI: 0.44-0.73) and higher education (AOR = 0.26, 95%CI: 0.19-0.37, p < 0.001) had significantly lower odds. Exposure to media was also protective (AOR = 0.76, 95%CI: 0.62-0.93). Women who reported that money for treatment (AOR = 1.25, 95%CI: 1.01-1.55) and distance to a health facility (AOR = 1.25, 95%CI: 1.01-1.55) were big problems had higher odds of unmet need. There was an inverse association between wealth status and unmet need, with poorest women having the highest odds of unmet need for breast cancer screening (AOR = 1.82, 95%CI: 1.29-2.57).
conclusionUnmet need for breast cancer screening is high in Ghana. Improving formal education, alleviating poverty and addressing health accessibility challenges could significantly reduce the high unmet need for breast cancer screening in Ghana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.